Business Description
RTW Biotech Opportunities Ltd
ISIN : GG00BKTRRM22
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.96 | |||||
Debt-to-EBITDA | N/A | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 7/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -18.1 | |||||
3-Year EPS without NRI Growth Rate | -18.7 | |||||
3-Year Book Growth Rate | -1.8 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 51.48 | |||||
9-Day RSI | 48.81 | |||||
14-Day RSI | 46.48 | |||||
6-1 Month Momentum % | -6.23 | |||||
12-1 Month Momentum % | 2.88 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.2 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Net Margin % | 96.4 | |||||
FCF Margin % | 38.87 | |||||
ROE % | 21.56 | |||||
ROA % | 19.74 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 3.94 | |||||
PE Ratio without NRI | 3.94 | |||||
PS Ratio | 3.8 | |||||
PB Ratio | 0.7 | |||||
Price-to-Tangible-Book | 0.69 | |||||
Price-to-Free-Cash-Flow | 9.86 | |||||
Price-to-Operating-Cash-Flow | 9.86 | |||||
EV-to-Revenue | 5.47 | |||||
EV-to-FCF | 14.13 | |||||
Price-to-Graham-Number | 0.35 | |||||
FCF Yield % | 7.06 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
RTW Biotech Opportunities Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 86.296 | ||
EPS (TTM) ($) | 0.36 | ||
Beta | 1.07 | ||
Volatility % | 30.7 | ||
14-Day RSI | 46.48 | ||
14-Day ATR ($) | 0.041126 | ||
20-Day SMA ($) | 1.414 | ||
12-1 Month Momentum % | 2.88 | ||
52-Week Range ($) | 1.255 - 1.73 | ||
Shares Outstanding (Mil) | 335.71 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
RTW Biotech Opportunities Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
RTW Biotech Opportunities Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
RTW Biotech Opportunities Ltd Frequently Asked Questions
What is RTW Biotech Opportunities Ltd(LSE:RTW)'s stock price today?
When is next earnings date of RTW Biotech Opportunities Ltd(LSE:RTW)?
Does RTW Biotech Opportunities Ltd(LSE:RTW) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |